Advanced Search

 

Study ID Status Title Patient Level Data
105517/162 Completed A randomised, double-blind, placebo-controlled, 21-day repeat dose parallel group study to assess the irritancy of intranasal administration of BRL 4910F mupirocin 5% nasal spray in healthy volunteers.
105517/163 Completed A pilot study on the efficacy and the safety of carvedilol in the elderly.
105517/164 Completed A double blind, randomized, placebo controlled trial to assess the efficacy of mupirocin in eradicating the nasopharyngeal colonization with Streptococcus pneumoniae, Haemophilus influenzae and/or Moraxella catarrhalis.
105517/177 Completed A pharmacokinetic study of a single oral dose of carvedilol 25mg administered to healthy elderly males compared to the same dose given to healthy young males.
105517/220 Completed A six-month, double-blind, placebo-controlled, multicenter dose-ranging comparison of oral carvedilol b.i.d. in patients with congestive heart failure, NYHA Class II-IV.
105517/221 Completed A six-month, double-blind, multicenter comparison of oral carvedilol b.i.d. with placebo in patients with congestive heart failure, NYHA Class II-IV.
105517/223 Completed A randomized trial of carvedilol (a beta-adrenergic antagonist with vasodilator properties) in patients with ischemic congestive cardiomyopathy.
105517/233 Completed Single- and Multiple-Dose Pharmacokinetics of Carvedilol and Enantiomers of Carvedilol in Patients with Congestive Heart Failure Compared to Normal Volunteers.
105517/234 Completed A study to determine the effect of carvedilol on the anticoagulant effect of warfarin and on the pharmacokinetics of warfarin enantiomers.
105517/236 Completed Multiple dose Pharmacokinetics of Carvedilol and its Enantiomers in Patients with Congestive Heart Failure.
105517/239 Completed A six-month, double-blind, multicenter comparison of oral carvedilol b.i.d. with placebo in patients with severe congestive heart failure, NYHA Class III-IV.
105517/240 Completed A twelve-month double-blind multicenter comparison of oral carvedilol b.i.d. with placebo in patients with mild congestive heart failure, NYHA Class II-III.
105517/269 Completed A multi-national, multi-centre, randomized, double-blind, parallel-group study to determine the effects of carvedilol on mortality and morbidity in patients with left ventricular dysfunction, with or without clinical evidence of heart failure, post myocardial infarction.
105517/287 Completed Carvedilol Prospective Randomized Cumulative Survival Trial. Study Listed on ClinicalStudyDataRequest.com
105517/321 Completed A multicenter, placebo-controlled, 8-month study of the effect of twice daily carvedilol in children with congestive heart failure due to systemic ventricular systolic dysfunction
105517/346 Completed A Randomized, Double-Blind, Multicenter Study Comparing the Glycemic Control Characteristics of Carvedilol and Metoprolol in Hypertensive Patients With Type II Diabetes Mellitus.
105517/347 Completed A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Carvedilol and Metoprolol on Glycemic Control in Hypertensive Patients with Type II Diabetes Mellitus.
105517/367 Completed A Randomized, Double-Blind, Multicenter Study Comparing the Effects of Administration of Modified Release COREG or Placebo on Blood Pressure in Essential Hypertension Patients Study Listed on ClinicalStudyDataRequest.com
105517/369 Completed An open, non-randomized comparison of pharmacokinetic profiles of carvedilol (SK&F-105517) MR and IR on repeat dosing in chronic CHF subjects and survivors of an acute MI and LVD Study Listed on ClinicalStudyDataRequest.com
105517/396 Completed A multicenter, open-label extension study to evaluate the safety of twice daily oral carvedilol in pediatric subjects with chronic heart failure (including results of Study 321 Open Label phase [321OL])
105517/902 Completed A Randomized, Double-Blind, Placebo-Controlled, PK/PD Modeling, Multicenter Study to Compare the B1-Blocking Effects of an investigational formulation of carvedilol to COREG Immediate Release Tablets at Steady-State in Adult Patients with Essential Hypertension, by Evaluating Heart Rate Response to Bicycle Ergometry Study Listed on ClinicalStudyDataRequest.com
105517/906 Completed An Open-label, Single Dose, Three Session, Partially Randomized, Crossover Study to Assess Morning and Evening Dosing of Carvedilol Phosphate MR Capsules in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
105517/908 Completed A randomized, single-blind, placebo-controlled, three-period parallel-group study to assess the pharmacokinetic and pharmacodynamic relationship of a 50 mg single oral dose of immediate release carvedilol in healthy subjects Study Listed on ClinicalStudyDataRequest.com
105533 Completed A randomized, open-label, single-dose, four-period cross-over study to evaluate the relative bioavailability of four formulations of GSK lisinopril compared to Zestril, and to compare over-encapsulated Zestril to Zestril Study Listed on ClinicalStudyDataRequest.com
105539 Completed An open, randomized, phase IIIa study to evaluate the safety and immunogenicity of GSK Biologicals' 10-valent pneumococcal conjugate vaccine, when administered intramuscularly according to a 2-4-11 months vaccination schedule Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.